Ibrahim, Absar K.

HRN: 22-11-22  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
CEFTRIAXONE 1G (VIAL)
10/24/2022
10/30/2022
IV
2g
Q24
Sepsis; Generalized Peritonitis
Waiting Final Action 
10/24/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/24/2022
10/24/2022
IV
500mg
Q8
Sepsis; Generalized Peritonitis
Waiting Final Action 
11/02/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/02/2022
11/03/2022
IV
500mg
Q8
Typhoid Ilitis S/p EL
Waiting Final Action 
11/02/2022
CEFTRIAXONE 1G (VIAL)
11/02/2022
11/03/2022
IV
2gm
Q24
Typhoid Ilitis S/p EL
Waiting Final Action 
11/02/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/02/2022
11/03/2022
IV
500mg
Q8
Typhoid Ilitis S/p EL
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: